AI is rapidly changing how we work, live, and make decisions. But what happens when that transformation reaches healthcare and ultimately, the patient?

In this episode of The Early Signs Podcast, our Co-Founder and CEO Prashant Warier sits down with Dr. Sunil Verma, SVP & Global Head of Oncology at AstraZeneca, for a wide-ranging conversation on what AI could mean for the future of healthcare and humanity.

From giving patients a stronger voice in their own care to transforming clinical decision-making, drug discovery, and healthcare delivery, Dr. Verma explores both the possibilities and the challenges that lie ahead.

He believes the next three years could define the incredible opportunity AI has to unleash.

Together, they explore:

* How AI could give patients a stronger voice in their own care

* Why treatment decisions may become increasingly complex as options multiply

* The promise and limitations of AI in drug discovery and clinical trials

* What it could take to move from "sick care" to more proactive, continuous care

* How organisations can build AI literacy and adoption

* The ethical guardrails needed as AI becomes more powerful

If you work in healthcare, life sciences, technology, or are simply curious about where AI is headed—this conversation offers a look at what comes next.

Guest:

Dr. Sunil Verma

SVP & Global Head, Oncology Franchise, AstraZeneca

Host:

Prashant Warier

Co-Founder & CEO, Qure.ai